Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer

Andtbacka, 2015, Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma, J. Clin. Oncol., 33, 2780, 10.1200/JCO.2014.58.3377 Miest, 2014, New viruses for cancer therapy: meeting clinical needs, Nat. Rev. Microbiol., 12, 23, 10.1038/nrmicro3140 Pol, 2015, Trial Watch-Oncolytic viruses and cancer therapy, OncoImmunology, 5, e1117740, 10.1080/2162402X.2015.1117740 Haddad, 2017, Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery, Front. Oncol., 7, 96, 10.3389/fonc.2017.00096 McFadden, 2005, Poxvirus tropism, Nat. Rev. Microbiol., 3, 201, 10.1038/nrmicro1099 Shen, 2005, Fighting cancer with vaccinia virus: teaching new tricks to an old dog, Mol. Ther., 11, 180, 10.1016/j.ymthe.2004.10.015 Guo, 2019, Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics, J. Immunother. Cancer, 7, 6, 10.1186/s40425-018-0495-7 Kim, 2006, Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF, Mol. Ther., 14, 361, 10.1016/j.ymthe.2006.05.008 Breitbach, 2011, Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans, Nature, 477, 99, 10.1038/nature10358 Foloppe, 2019, The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism, Mol. Ther. Oncolytics, 14, 1, 10.1016/j.omto.2019.03.005 Erbs, 2000, In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene, Cancer Res., 60, 3813 Gondo, 2009, Next-generation gene targeting in the mouse for functional genomics, BMB Rep., 42, 315, 10.5483/BMBRep.2009.42.6.315 Gray, 2020, Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer, Front. Oncol., 10, 617, 10.3389/fonc.2020.00617 Visan, 2016, In vitro comparative models for canine and human breast cancers, Clujul Med., 89, 38 Donnay, 1995, Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs, Am. J. Vet. Res., 56, 1188 Ahern, 1996, Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines, Am. J. Vet. Res., 57, 693 Kumaraguruparan, 2006, Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours, Res. Vet. Sci., 81, 218, 10.1016/j.rvsc.2005.08.002 Sleeckx, 2011, Canine mammary tumours, an overview, Reprod. Domest. Anim., 46, 1112, 10.1111/j.1439-0531.2011.01816.x Shinoda, 2014, Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor, J. Vet. Diagn. Invest., 26, 390, 10.1177/1040638714527289 Moe, 2001, Population-based incidence of mammary tumours in some dog breeds, J. Reprod. Fertil. Suppl., 57, 439 Else, 1982, The characteristics of a canine mammary carcinoma cell line, REM 134, Br. J. Cancer, 46, 675, 10.1038/bjc.1982.254 Binn, 1980, Establishment of a canine cell line: derivation, characterization, and viral spectrum, Am. J. Vet. Res., 41, 855 Peña, 2013, Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics, Vet. Pathol., 50, 94, 10.1177/0300985812447830 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 DeSantis, 2015, International Variation in Female Breast Cancer Incidence and Mortality Rates, Cancer Epidemiol. Biomarkers Prev., 24, 1495, 10.1158/1055-9965.EPI-15-0535 Merlo, 2008, Cancer incidence in pet dogs: findings of the Animal Tumor Registry of Genoa, Italy, J. Vet. Intern. Med., 22, 976, 10.1111/j.1939-1676.2008.0133.x Beauvais, 2012, The effect of neutering on the risk of mammary tumours in dogs--a systematic review, J. Small Anim. Pract., 53, 314, 10.1111/j.1748-5827.2011.01220.x Schneider, 1969, Factors influencing canine mammary cancer development and postsurgical survival, J. Natl. Cancer Inst., 43, 1249 Vail, 2000, Spontaneously occurring tumors of companion animals as models for human cancer, Cancer Invest., 18, 781, 10.3109/07357900009012210 Porrello, 2006, Oncology of companion animals as a model for humans. an overview of tumor histotypes, J. Exp. Clin. Cancer Res., 25, 97 Uva, 2009, Comparative expression pathway analysis of human and canine mammary tumors, BMC Genomics, 10, 135, 10.1186/1471-2164-10-135 Rivera, 2011, Molecular biological aspects on canine and human mammary tumors, Vet. Pathol., 48, 132, 10.1177/0300985810387939 Pinho, 2012, Canine tumors: a spontaneous animal model of human carcinogenesis, Transl. Res., 159, 165, 10.1016/j.trsl.2011.11.005 Abdelmegeed, 2018, Canine mammary tumors as a model for human disease, Oncol. Lett., 15, 8195 Bernstein, 2002, Epidemiology of endocrine-related risk factors for breast cancer, J. Mammary Gland Biol. Neoplasia, 7, 3, 10.1023/A:1015714305420 Foloppe, 2008, Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus, Gene Ther., 15, 1361, 10.1038/gt.2008.82 Fend, 2015, Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment, OncoImmunology, 5, e1080414, 10.1080/2162402X.2015.1080414 Fend, 2017, Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy, Cancer Res., 77, 4146, 10.1158/0008-5472.CAN-16-2165 Vinci, 2012, Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation, BMC Biol., 10, 29, 10.1186/1741-7007-10-29 Finocchiaro, 2004, Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids, Cancer Gene Ther., 11, 333, 10.1038/sj.cgt.7700682 Kostova, 2015, An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment, Cancer Gene Ther., 22, 30, 10.1038/cgt.2014.67 Loessner, 2010, Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells, Biomaterials, 31, 8494, 10.1016/j.biomaterials.2010.07.064 Millerot-Serrurot, 2010, 3D collagen type I matrix inhibits the antimigratory effect of doxorubicin, Cancer Cell Int., 10, 26, 10.1186/1475-2867-10-26 Borrell, 2010, How accurate are cancer cell lines?, Nature, 463, 858, 10.1038/463858a Weinstein, 2012, Drug discovery: Cell lines battle cancer, Nature, 483, 544, 10.1038/483544a Day, 2015, Preclinical mouse cancer models: a maze of opportunities and challenges, Cell, 163, 39, 10.1016/j.cell.2015.08.068 Garden, 2018, Companion animals in comparative oncology: One Medicine in action, Vet. J., 240, 6, 10.1016/j.tvjl.2018.08.008 Kloker, 2018, Three-dimensional tumor cell cultures employed in virotherapy research, Oncolytic Virother., 7, 79, 10.2147/OV.S165479 Wu, 2018, Precision-cut human liver slice cultures as an immunological platform, J. Immunol. Methods, 455, 71, 10.1016/j.jim.2018.01.012 Dame, 2010, Human colon tissue in organ culture: preservation of normal and neoplastic characteristics, In Vitro Cell. Dev. Biol. Anim., 46, 114, 10.1007/s11626-009-9247-9 Autio, 2016, Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies, Vet. Comp. Oncol., 14, 395, 10.1111/vco.12119 Duntsch, 2004, Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model, J. Neurosurg., 100, 1049, 10.3171/jns.2004.100.6.1049 Stoff-Khalili, 2005, Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system, Breast Cancer Res., 7, R1141, 10.1186/bcr1353 Pennington, 2010, The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adenoviruses, J. Surg. Res., 163, 270, 10.1016/j.jss.2010.03.072 Potts, 2017, Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models, EMBO Mol. Med., 9, 638, 10.15252/emmm.201607296 Udden, 2017, The Ex Vivo Colon Organ Culture and Its Use in Antimicrobial Host Defense Studies, J. Vis. Exp. Erbs, 2008, Modified vaccinia virus Ankara as a vector for suicide gene therapy, Cancer Gene Ther., 15, 18, 10.1038/sj.cgt.7701098